Advance of improvment of the prediction on cardiovascular toxicity in the drug developmentWANG Ju-feng2753-2758
Analysis and enlightenment of the main problems of data integrality in FDA warning lettersYANG Zhu-ren, ZHAO Shuang-chun, ZHAO Hong-ju2759-2763
Bezlotoxumab——a new human monoclonal antibody for the prevention of Clostridium difficile infectionLI Chun-xing, LIU Hua2764-2766
Reproductive and developmental toxicity of the marketed anti-diabetic agents for type 2 diabetic mellitusYU Shan-shan, YIN Hua-jing, ZHOU Heng, WANG Qing-li, HU Xiao-min2772-2779
Research progress on continuous production and process control technology of oral solid dosage formsTONG Yong-tao, GAO Chun-hong, GAO Chun-sheng2780-2787
Absorption mechanism of kirenol and pharmacokinetic analysis of its sustained-release pellets in beaglesHE Dong-mei, GUAN Shi-xia, FU Hong-zheng, LU Shu-fan, ZHOU Xiang-ping2788-2793
Factors affecting the efficacy of clopidogrel and its metabolismSHENG Guo-tai, XU Xiu-xiu, GE Yu-zhi2794-2798
Pathogenesis of Alzheimer's disease and the therapeutic mechanism of natural polyphenolsLIU Shi-xian, MAO Lin-fei, YU Fan, ZHANG Yu-bo, GAO Xiao-ling2799-2804
Application progress of nanomedicines in the treatment of strokeLIANG Xin-tong, LI Qiang, XUE Ming, ZHAO Yu-ming2805-2811